[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f3rTH978c0qfghx0GSZ_RMqUEsXQCW72u9u6h4f3kSAg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":8,"totalEnrollment":9,"activePrograms":8,"nonDrugCount":10,"topConditions":11,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Centre d'Investigation Clinique et Technologique 805",[4],75,false,0,7616,69,[12,15,18,21,24,27,30,32],{"name":13,"count":14},"Neuromuscular Disease",9,{"name":16,"count":17},"Neuromuscular Diseases",7,{"name":19,"count":20},"Respiratory Failure",6,{"name":22,"count":23},"Stroke",4,{"name":25,"count":26},"Neuromuscular Disorder",3,{"name":28,"count":29},"Gait",2,{"name":31,"count":29},"Traumatic Brain Injury",{"name":33,"count":29},"Muscular Dystrophies",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,72,98,124,152,178],{"intervention":44,"totalTrials":45,"cells":46},"fecal microbiota transplant",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":70},{"trials":48,"activeCount":8},[],{"trials":50,"activeCount":8},[],{"trials":52,"activeCount":8},[],{"trials":54,"activeCount":8},[],{"trials":56,"activeCount":8},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":69},"NCT03029078","FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?","COMPLETED",[40],"2020-12-01","2014-11-01",50,[66,67,68],"Microbial Colonization","Bacterial Peritonitis","Faeces Smearing",[44],{"trials":71,"activeCount":8},[],{"intervention":73,"totalTrials":45,"cells":74},"detrusor infection of Botulinum toxin",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":85},{"trials":76,"activeCount":8},[],{"trials":78,"activeCount":8},[],{"trials":80,"activeCount":8},[],{"trials":82,"activeCount":8},[],{"trials":84,"activeCount":8},[],{"trials":86,"activeCount":8},[87],{"nctId":88,"briefTitle":89,"status":60,"phases":90,"primaryCompletion":91,"completion":92,"start":93,"enrollment":94,"conditions":95,"interventions":97},"NCT03042052","Toxin Retrospective Study",[],"2016-05-01","2016-06-01","2014-01-01",292,[96],"Neurogenic Bladder",[73],{"intervention":99,"totalTrials":45,"cells":100},"4cc of lidocaïne®",{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":111},{"trials":102,"activeCount":8},[],{"trials":104,"activeCount":8},[],{"trials":106,"activeCount":8},[],{"trials":108,"activeCount":8},[],{"trials":110,"activeCount":8},[],{"trials":112,"activeCount":8},[113],{"nctId":114,"briefTitle":115,"status":60,"phases":116,"primaryCompletion":117,"completion":118,"start":119,"enrollment":120,"conditions":121,"interventions":123},"NCT02455232","Determine the Main Muscle Participant in the Deformation of the Elbow in Hemiplegic Patients",[41],"2015-07","2016-01","2015-05",20,[122],"Hemiplegia",[99],{"intervention":125,"totalTrials":45,"cells":126},"Eosinophil count",{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":137},{"trials":128,"activeCount":8},[],{"trials":130,"activeCount":8},[],{"trials":132,"activeCount":8},[],{"trials":134,"activeCount":8},[],{"trials":136,"activeCount":8},[],{"trials":138,"activeCount":8},[139],{"nctId":140,"briefTitle":141,"status":60,"phases":142,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":147,"interventions":151},"NCT04734431","Interest of Eosinopenia to Predict In-hospital Mortality Among Elderly Patients",[],"2018-12-31","2020-01-01","2018-01-01",224,[148,149,150],"Death","Bacterial Infections","Elderly Infection",[125],{"intervention":153,"totalTrials":45,"cells":154},"favorable outcome",{"EARLY_PHASE1":155,"PHASE1":157,"PHASE2":159,"PHASE3":161,"PHASE4":163,"NA":165},{"trials":156,"activeCount":8},[],{"trials":158,"activeCount":8},[],{"trials":160,"activeCount":8},[],{"trials":162,"activeCount":8},[],{"trials":164,"activeCount":8},[],{"trials":166,"activeCount":8},[167],{"nctId":168,"briefTitle":169,"status":60,"phases":170,"primaryCompletion":171,"completion":171,"start":172,"enrollment":173,"conditions":174,"interventions":177},"NCT04453501","Anti Infective Agents Impact in COVID-19 Pneumonia",[],"2020-04-25","2020-03-02",132,[175,176],"COVID","Pneumonia, Viral",[153],{"intervention":179,"totalTrials":45,"cells":180},"Gabapentin",{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":187,"PHASE4":189,"NA":191},{"trials":182,"activeCount":8},[],{"trials":184,"activeCount":8},[],{"trials":186,"activeCount":8},[],{"trials":188,"activeCount":8},[],{"trials":190,"activeCount":8},[],{"trials":192,"activeCount":8},[193],{"nctId":194,"briefTitle":195,"status":60,"phases":196,"primaryCompletion":197,"completion":197,"start":198,"enrollment":199,"conditions":200,"interventions":203},"NCT03149432","Effectiveness of Mirror Therapy in Patients With Amputations of Lower Limbs of Vascular Origin",[41],"2019-08-31","2017-02-22",30,[201,202],"Amputation","Phantom Pain Following Amputation of Lower Limb",[179]]